When to contact your GP: Persistent or severe nausea/vomiting preventing adequate fluid intake Severe, persistent abdominal pain which could indicate pancreatitis New or worsening depression, anxiety, or suicidal thoughts Severe headaches or visual disturbances Unexplained cognitive changes or confusion Signs of hypoglycaemia (if taking alongside insulin or sulfonylureas) NICE guidance recommends regular monitoring during GLP-1 receptor agonist therapy
Additionally, cardiometabolic conditions, including blood pressure and cholesterol, show improvement in the presence of Retatrutide
Questions to Ask Your Healthcare Provider: See Also Tips to Check Lexapro and Semaglutide Interactions At the time of considering the combination of Lexapro and Wegovy, patients may find it beneficial to have proactive discussions with their healthcare providers
Many patients show an average of 1020% total body weight loss over 612 months, depending on dosage, adherence, and individual metabolism
10.1038/s41392-023-01619-w 227 ZimhonyO.VilchzeC.AraiM.WelchJ